[
  {
    "ts": "2025-11-25T08:44:00+00:00",
    "headline": "The Zacks Analyst Blog Highlights LLY, EPHE, BBC, HELX, XHS and SURI",
    "summary": "LLY, EPHE, BBC, HELX, XHS and SURI headline last week's top-performing ETFs as healthcare and biotech outperform a weak broader market.",
    "url": "https://finance.yahoo.com/news/zacks-analyst-blog-highlights-lly-084400821.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "99c618a7-63cd-36e3-8007-79d32035e4df",
      "content": {
        "id": "99c618a7-63cd-36e3-8007-79d32035e4df",
        "contentType": "STORY",
        "title": "The Zacks Analyst Blog Highlights LLY, EPHE, BBC, HELX, XHS and SURI",
        "description": "",
        "summary": "LLY, EPHE, BBC, HELX, XHS and SURI headline last week's top-performing ETFs as healthcare and biotech outperform a weak broader market.",
        "pubDate": "2025-11-25T08:44:00Z",
        "displayTime": "2025-11-25T08:44:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/60c096e1e24bb285c41a58d325d8d707",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/MjuR.4zEKm0FgKsxK.lBKQ--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/60c096e1e24bb285c41a58d325d8d707.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/G.VCDKzJSEg_sv.1sSAJrQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/60c096e1e24bb285c41a58d325d8d707.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/zacks-analyst-blog-highlights-lly-084400821.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/zacks-analyst-blog-highlights-lly-084400821.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            },
            {
              "symbol": "BBC"
            },
            {
              "symbol": "XHS"
            },
            {
              "symbol": "SURI"
            },
            {
              "symbol": "EPHE"
            },
            {
              "symbol": "^SPX"
            },
            {
              "symbol": "^DJI"
            },
            {
              "symbol": "^IXIC"
            },
            {
              "symbol": "NVDA"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-25T11:38:00+00:00",
    "headline": "Citizens Financial Group And 2 Other Stocks That May Be Priced Below Their Estimated Worth",
    "summary": "As the U.S. stock market kicks off a holiday-shortened trading week with significant gains, investors are buoyed by optimism around a potential Federal Reserve interest rate cut in December. In this environment of heightened confidence, identifying stocks that may be undervalued compared to their estimated worth can be particularly appealing, as they offer opportunities for growth amidst broader market enthusiasm.",
    "url": "https://finance.yahoo.com/news/citizens-financial-group-2-other-113800081.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "8e7d5279-e52c-301b-885a-fc96dc1820fa",
      "content": {
        "id": "8e7d5279-e52c-301b-885a-fc96dc1820fa",
        "contentType": "STORY",
        "title": "Citizens Financial Group And 2 Other Stocks That May Be Priced Below Their Estimated Worth",
        "description": "",
        "summary": "As the U.S. stock market kicks off a holiday-shortened trading week with significant gains, investors are buoyed by optimism around a potential Federal Reserve interest rate cut in December. In this environment of heightened confidence, identifying stocks that may be undervalued compared to their estimated worth can be particularly appealing, as they offer opportunities for growth amidst broader market enthusiasm.",
        "pubDate": "2025-11-25T11:38:00Z",
        "displayTime": "2025-11-25T11:38:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/a192a90509b207df974cc973e0c18172",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/zcvqJ.rdXZ_29KqIsTLT6w--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/a192a90509b207df974cc973e0c18172.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/DcBS7NpZ60GKZMC5QwFweA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/a192a90509b207df974cc973e0c18172.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/citizens-financial-group-2-other-113800081.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/citizens-financial-group-2-other-113800081.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CFG"
            },
            {
              "symbol": "CFG-PE"
            },
            {
              "symbol": "VRT"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "WBTN"
            },
            {
              "symbol": "CROX"
            },
            {
              "symbol": "SHC"
            },
            {
              "symbol": "PRSO"
            },
            {
              "symbol": "NIC"
            },
            {
              "symbol": "FITB"
            },
            {
              "symbol": "HBAN"
            },
            {
              "symbol": "FRSH"
            },
            {
              "symbol": "BUSE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-25T13:40:37+00:00",
    "headline": "Redditors Are Buying Eli Lilly And Co (LLY) Ahead of Potential End of AI Trade. Here’s Why",
    "summary": "We recently published Top 10 Non-AI Stocks Redditors are Buying Ahead of Potential Bubble Burst. Eli Lilly And Co (NYSE:LLY) is one of the top non-AI stocks redditors are buying. Eli Lilly And Co (NYSE:LLY) recently posted strong quarterly results amid robust growth from its diabetes and weight-loss products. With a diverse portfolio spanning oncology, […]",
    "url": "https://finance.yahoo.com/news/redditors-buying-eli-lilly-co-134037570.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "ae5d267c-0c77-3229-8fbf-c74e98a921d3",
      "content": {
        "id": "ae5d267c-0c77-3229-8fbf-c74e98a921d3",
        "contentType": "STORY",
        "title": "Redditors Are Buying Eli Lilly And Co (LLY) Ahead of Potential End of AI Trade. Here’s Why",
        "description": "",
        "summary": "We recently published Top 10 Non-AI Stocks Redditors are Buying Ahead of Potential Bubble Burst. Eli Lilly And Co (NYSE:LLY) is one of the top non-AI stocks redditors are buying. Eli Lilly And Co (NYSE:LLY) recently posted strong quarterly results amid robust growth from its diabetes and weight-loss products. With a diverse portfolio spanning oncology, […]",
        "pubDate": "2025-11-25T13:40:37Z",
        "displayTime": "2025-11-25T13:40:37Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/7746a495763c517cd6ea96985a667439",
          "originalWidth": 1920,
          "originalHeight": 1280,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/L.y5eHntIJd0XzA2FsxbTA--~B/aD0xMjgwO3c9MTkyMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/insidermonkey.com/7746a495763c517cd6ea96985a667439.cf.webp",
              "width": 1920,
              "height": 1280,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/6ji6jibByYrwJ8.gSBa.ig--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/7746a495763c517cd6ea96985a667439.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/redditors-buying-eli-lilly-co-134037570.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/redditors-buying-eli-lilly-co-134037570.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-25T10:52:29+00:00",
    "headline": "How Is Eli Lilly’s Stock Performance Compared to Other Pharmaceuticals?",
    "summary": "Eli Lilly’s remarkable outperformance within the pharmaceutical sector hasn’t tempered enthusiasm, analysts are still strongly bullish on its long-term growth potential.",
    "url": "https://www.barchart.com/story/news/36300459/how-is-eli-lillys-stock-performance-compared-to-other-pharmaceuticals",
    "source": "Barchart",
    "provider": "yfinance",
    "raw": {
      "id": "b2f7de19-997c-33af-bd1f-ad5d30a86540",
      "content": {
        "id": "b2f7de19-997c-33af-bd1f-ad5d30a86540",
        "contentType": "STORY",
        "title": "How Is Eli Lilly’s Stock Performance Compared to Other Pharmaceuticals?",
        "description": "",
        "summary": "Eli Lilly’s remarkable outperformance within the pharmaceutical sector hasn’t tempered enthusiasm, analysts are still strongly bullish on its long-term growth potential.",
        "pubDate": "2025-11-25T10:52:29Z",
        "displayTime": "2025-11-25T10:52:29Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/barchart_com_477/3eb006d76a84a0a4b0ebac5f8867f9c6",
          "originalWidth": 1600,
          "originalHeight": 1067,
          "caption": "Eli Lilly & Co_ by Tada Images via Shutterstock",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ORmCiaC7fQ4pnNEnWgm3oQ--~B/aD0xMDY3O3c9MTYwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/barchart_com_477/3eb006d76a84a0a4b0ebac5f8867f9c6.cf.webp",
              "width": 1600,
              "height": 1067,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/C3HoxXjqH6nltkp.0HDWtQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/barchart_com_477/3eb006d76a84a0a4b0ebac5f8867f9c6.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Barchart",
          "url": "https://www.barchart.com/"
        },
        "canonicalUrl": {
          "url": "https://www.barchart.com/story/news/36300459/how-is-eli-lillys-stock-performance-compared-to-other-pharmaceuticals",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/eli-lilly-stock-performance-compared-105229582.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-25T12:47:00+00:00",
    "headline": "Healthcare ETF (IYH) Hits New 52-Week High",
    "summary": "IYH hits a 52-week high as healthcare gains momentum, lifted by sector strength and rising investor interest in safety and AI-driven tailwinds.",
    "url": "https://finance.yahoo.com/news/healthcare-etf-iyh-hits-52-124700773.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "33c40ab5-ff68-3efe-bb47-16235841b1ca",
      "content": {
        "id": "33c40ab5-ff68-3efe-bb47-16235841b1ca",
        "contentType": "STORY",
        "title": "Healthcare ETF (IYH) Hits New 52-Week High",
        "description": "",
        "summary": "IYH hits a 52-week high as healthcare gains momentum, lifted by sector strength and rising investor interest in safety and AI-driven tailwinds.",
        "pubDate": "2025-11-25T12:47:00Z",
        "displayTime": "2025-11-25T12:47:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/ec93e4a47652cf9206c52a690222a4bc",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/nsldjkB1K_SFHVsIPsuFdw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/ec93e4a47652cf9206c52a690222a4bc.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/VSYOLBAit2H.4TUzzWsjvA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/ec93e4a47652cf9206c52a690222a4bc.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/healthcare-etf-iyh-hits-52-124700773.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/healthcare-etf-iyh-hits-52-124700773.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "IYH"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-25T12:24:00+00:00",
    "headline": "J&J Up Around 17% in 3 Months: Should You Buy, Sell or Hold the Stock?",
    "summary": "J&J's 16.7% rise reflects stronger sales guidance, rapid pipeline advances and improving MedTech momentum amid a recovering sector.",
    "url": "https://finance.yahoo.com/news/j-j-around-17-3-122400598.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "8392a715-958e-3f0a-b30d-1fda5fff8259",
      "content": {
        "id": "8392a715-958e-3f0a-b30d-1fda5fff8259",
        "contentType": "STORY",
        "title": "J&J Up Around 17% in 3 Months: Should You Buy, Sell or Hold the Stock?",
        "description": "",
        "summary": "J&J's 16.7% rise reflects stronger sales guidance, rapid pipeline advances and improving MedTech momentum amid a recovering sector.",
        "pubDate": "2025-11-25T12:24:00Z",
        "displayTime": "2025-11-25T12:24:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/9883d206905e7516b2353476e213e60c",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/WtA490SSyXq.BB5XEEYFSg--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9883d206905e7516b2353476e213e60c.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/BdQSUWaJAMCKg7gp75c9jQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9883d206905e7516b2353476e213e60c.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/j-j-around-17-3-122400598.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/j-j-around-17-3-122400598.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "NVO"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-25T08:00:00+00:00",
    "headline": "4 takeaways from pharma’s manufacturing boom",
    "summary": "As pharma’s U.S. facility investments top $370 billion over the next five years, there are a few things to keep in mind, according to construction experts.",
    "url": "https://www.pharmavoice.com/news/pharma-manufacturing-boom-takeaways/806347/",
    "source": "Pharma Voice",
    "provider": "yfinance",
    "raw": {
      "id": "7eddfa3d-98b0-310a-9cbc-1410d8520d34",
      "content": {
        "id": "7eddfa3d-98b0-310a-9cbc-1410d8520d34",
        "contentType": "STORY",
        "title": "4 takeaways from pharma’s manufacturing boom",
        "description": "",
        "summary": "As pharma’s U.S. facility investments top $370 billion over the next five years, there are a few things to keep in mind, according to construction experts.",
        "pubDate": "2025-11-25T08:00:00Z",
        "displayTime": "2025-11-25T08:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/pharma_voice_330/55be0bf0554fdae9f49f7f23956f3bc7",
          "originalWidth": 1600,
          "originalHeight": 900,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/u9czpu1ZeOo83B1Iq3OOWQ--~B/aD05MDA7dz0xNjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/pharma_voice_330/55be0bf0554fdae9f49f7f23956f3bc7.cf.webp",
              "width": 1600,
              "height": 900,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/gTwKjxJU4WV1UEhIzppTlA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/pharma_voice_330/55be0bf0554fdae9f49f7f23956f3bc7.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Pharma Voice",
          "url": "https://www.pharmavoice.com/"
        },
        "canonicalUrl": {
          "url": "https://www.pharmavoice.com/news/pharma-manufacturing-boom-takeaways/806347/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/4-takeaways-pharma-manufacturing-boom-080000234.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MRK"
            },
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "NVS"
            },
            {
              "symbol": "RHHBF"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-25T14:51:00+00:00",
    "headline": "Novo Nordisk Stock Jumps on Positive Weight-Loss Drug Data. Why It Deserves Better.",
    "summary": "Shares, though, were punished Monday after the drug maker said its blockbuster obesity treatment Wegovy failed to slow Alzheimer’s.",
    "url": "https://www.barrons.com/articles/novo-nordisk-stock-weight-loss-drug-eli-lilly-f60c2b24?siteid=yhoof2&yptr=yahoo",
    "source": "Barrons.com",
    "provider": "yfinance",
    "raw": {
      "id": "dfbee025-d83a-3693-ad56-a484ddabe36c",
      "content": {
        "id": "dfbee025-d83a-3693-ad56-a484ddabe36c",
        "contentType": "STORY",
        "title": "Novo Nordisk Stock Jumps on Positive Weight-Loss Drug Data. Why It Deserves Better.",
        "description": "",
        "summary": "Shares, though, were punished Monday after the drug maker said its blockbuster obesity treatment Wegovy failed to slow Alzheimer’s.",
        "pubDate": "2025-11-25T14:51:00Z",
        "displayTime": "2025-11-25T14:51:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/dfbee025-d83a-3693-ad56-a484ddabe36c/novo-nordisk-stock-jumps-on.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/Barrons.com/019f884130a6e200476be84a3ab8457a",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ZSFoYvCd8e.k8vl3TWvLsg--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Barrons.com/019f884130a6e200476be84a3ab8457a.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/gOhtizi3tDMbrEr9yGeQEA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Barrons.com/019f884130a6e200476be84a3ab8457a.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Barrons.com",
          "url": "http://www.barrons.com/"
        },
        "canonicalUrl": {
          "url": "https://www.barrons.com/articles/novo-nordisk-stock-weight-loss-drug-eli-lilly-f60c2b24?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NVO"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "NONOF"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-25T14:47:00+00:00",
    "headline": "Novo Nordisk Drug Helps Patients Lose Weight, Lower Blood Sugar in Trial",
    "summary": "The pharma giant said amycretin helped patients lose weight and reduce blood-sugar levels in pill and injection forms during a mid-stage trial, lifting shares in the company.",
    "url": "https://www.wsj.com/health/pharma/novo-nordisk-says-new-obesity-drug-helps-patients-lose-weight-in-mid-stage-trial-ce87171f?siteid=yhoof2&yptr=yahoo",
    "source": "The Wall Street Journal",
    "provider": "yfinance",
    "raw": {
      "id": "6baa046b-8b30-3a62-83e7-1ff37bdfb168",
      "content": {
        "id": "6baa046b-8b30-3a62-83e7-1ff37bdfb168",
        "contentType": "STORY",
        "title": "Novo Nordisk Drug Helps Patients Lose Weight, Lower Blood Sugar in Trial",
        "description": "",
        "summary": "The pharma giant said amycretin helped patients lose weight and reduce blood-sugar levels in pill and injection forms during a mid-stage trial, lifting shares in the company.",
        "pubDate": "2025-11-25T14:47:00Z",
        "displayTime": "2025-11-25T14:47:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/6baa046b-8b30-3a62-83e7-1ff37bdfb168/novo-nordisk-drug-helps.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/wsj.com/6a7c78c25f6e6db2b81c83134ab9aad5",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/LLMQ.FBU5_TZC1NTldxM7Q--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/wsj.com/6a7c78c25f6e6db2b81c83134ab9aad5.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/6NHuFfgdqE3ajmE8GfufTQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/wsj.com/6a7c78c25f6e6db2b81c83134ab9aad5.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "The Wall Street Journal",
          "url": "http://www.wsj.com/"
        },
        "canonicalUrl": {
          "url": "https://www.wsj.com/health/pharma/novo-nordisk-says-new-obesity-drug-helps-patients-lose-weight-in-mid-stage-trial-ce87171f?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NVO"
            },
            {
              "symbol": "NOVO.B"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]